NRP2 and neoplasm: Utilizing these models, we demonstrate that in multiple models of cancer, cotargeting the endothelial expression of both NRP1 and NRP2 severely inhibits primary and secondary tumor growth and angiogenesis, to a much greater extent than when either NRP receptor is targeted alone.